Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 35 (11), 689-92

Caution Should Be Used in Long-Term Treatment With Oral Compounds of Hyaluronic Acid in Patients With a History of Cancer

Affiliations

Caution Should Be Used in Long-Term Treatment With Oral Compounds of Hyaluronic Acid in Patients With a History of Cancer

Procopio Simone et al. Clin Drug Investig.

Abstract

Intra-articular administration of hyaluronic acid is a valuable therapeutic tool for the management of patients with osteoarthritis. However, in recent years numerous formulations containing hyaluronic acid administrable by oral route have entered the market. Even if there are some data in the literature that have shown their effectiveness, systemic administration may expose a greater risk in certain situations. In fact, although hyaluronic acid is not considered a drug it is certain that it can interact with specific receptors and promote cell proliferation. This interaction may be potentially hazardous in cancer patients for which these oral formulations should be contraindicated.

Similar articles

See all similar articles

Cited by 1 PubMed Central articles

References

    1. Cancer Res. 1998 Jan 15;58(2):342-7 - PubMed
    1. Eur Rev Med Pharmacol Sci. 2013 Jul;17 (13):1752-9 - PubMed
    1. J Pain Res. 2015 May 07;8:217-28 - PubMed
    1. J Biol Chem. 2000 Jan 21;275(3):1829-38 - PubMed
    1. J Biol Chem. 2002 Mar 22;277(12):10050-7 - PubMed

MeSH terms

Substances

LinkOut - more resources

Feedback